These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 25234023)

  • 1. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
    Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
    Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
    Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
    J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
    Berry K; Ioannou GN
    Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG; Brooke-Smith M; Dolan P; Wilson TG; Padbury RT; Chen JW
    ANZ J Surg; 2013 May; 83(5):331-5. PubMed ID: 22943449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.
    Sumie S; Nakashima O; Okuda K; Kuromatsu R; Kawaguchi A; Nakano M; Satani M; Yamada S; Okamura S; Hori M; Kakuma T; Torimura T; Sata M
    Ann Surg Oncol; 2014 Mar; 21(3):1002-9. PubMed ID: 24254204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
    Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
    Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of incorporation of model for end-stage liver disease score with TNM staging in patients with hepatocellular carcinoma undergoing hepatic resection.
    Ling CH; Chau GY; Hsia CY; King KL
    Hepatogastroenterology; 2013; 60(125):1142-7. PubMed ID: 23803377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma.
    Cheng SJ; Freeman RB; Wong JB
    Liver Transpl; 2002 Apr; 8(4):323-8. PubMed ID: 11965574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.
    Cillo U; Vitale A; Brolese A; Zanus G; Neri D; Valmasoni M; Bonsignore P; Grigoletto F; Burra P; Farinati F; D'Amico DF
    J Surg Oncol; 2007 Mar; 95(3):213-20. PubMed ID: 17066432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
    Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
    Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.